FTSE battles with drugs

clock •

The FTSE 100 Index fell 23 points, or 0.4%, to 6,208 points today, led by drug companies GlaxoSmithKline and AstraZeneca.

GlaxoSmithKline declined 1.88% to £13.60 and AstraZeneca fell 2.11% to £30.10 on fears the US Congress will cut the price of drugs following Democrats triumph in the recent mid-term elections. The miners presented a mixed picture, as BHP Billiton fell 2.59% to £10.16 and Xstrata dropped 2.51% to £22.95, while Lonmin jumped 3.04% to £31.83 on the back of bid rumours. Anglo American rose 1.22% to £24.96 after the Oppenheimer family sold a third of its stake in the world's second-biggest miner to China Vision Resources. The transaction is worth around £419m. In the US, the Dow Jones i...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Watch Professional Adviser's Working Lunch with Baillie Gifford - Emerging Future: Rethinking the World's Growth Engine

Watch Professional Adviser's Working Lunch with Baillie Gifford - Emerging Future: Rethinking the World's Growth Engine

Catch up on the discussion

Professional Adviser
clock 13 October 2026 • 1 min read
Fifty years after 'Bogle's Folly', what comes next for financial advice?

Fifty years after 'Bogle's Folly', what comes next for financial advice?

'Indexing will continue to grow, but the wrapper through which investors access it will change'

Gillian Hepburn
clock 12 October 2026 • 4 min read
Chris Justham: Why the industry must 'entertain and engage' investors

Chris Justham: Why the industry must 'entertain and engage' investors

‘We can’t just offer them a dry cracker and ask them to chew it down’

Chris Justham
clock 07 October 2026 • 3 min read